Jan Puliński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jan Puliński has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Przelaskowska
Specialist Hospital named after F. Ceynowa in Wejherowo Dr.A Jagalskiego 10 84-200 Wejherowo Poland
7 shared publications - Karol Sikora
University of Pavol Jozef Šafárik, Košice, Slovakia
6 shared publications - Klaudia Płudowska
PCK Maritime Hospital, 1 Powstania Styczniowego Street, 81-519 Gdynia, Poland
6 shared publications - Marek Dróżdż
F. Ceynowa Specialilst Hospital in Wejherowo A. Jagalskiego 10, 84-200 Wejherowo
6 shared publications - Wiktoria Boral
F. Ceynowa Specialist Hospital in Wejherowo A. Jagalskiego 10, 84-200 Wejherowo
6 shared publications - Paulina Lewaśkiewicz
University of Pavol Jozef Šafárik, Košice, Slovakia
5 shared publications
Latest Publications
- Open Access
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
TRAUMATIC BRAIN INJURIES IN SPORT – A REVIEW OF CURRENT KNOWLEDGE ON PREVENTION, DIAGNOSIS AND TREATMENT
Sport-related traumatic brain injuries (SR TBI) represent a significant public health issue, the importance of which continues to grow alongside the global increase in recreational physical activity. Projections indicate that the incidence of traumatic brain injuries (TBI) will remain high through 2025, potentially reaching up to 70 million cases annually. TBI not only results in acute neurological symptoms, including the potentially fatal second impact syndrome, but can also lead to severe long-term consequences such as chronic traumatic encephalopathy (CTE). Understanding the pathophysiological mechanisms, epidemiology, and available diagnostic and therapeutic strategies is crucial for reducing risk and improving treatment outcomes of these injuries.
- 2 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessTRAUMATIC BRAIN INJURIES IN SPORT – A REVIEW OF CURRENT KNOWLEDGE ON PREVENTION, DIAGNOSIS AND TREATMENT
Sport-related traumatic brain injuries (SR TBI) represent a significant public health issue, the importance of which continues to grow alongside the global increase in recreational physical activity. Projections indicate that the incidence of traumatic brain injuries (TBI) will remain high through 2025, potentially reaching up to 70 million cases annually. TBI not only results in acute neurological symptoms, including the potentially fatal second impact syndrome, but can also lead to severe long-term consequences such as chronic traumatic encephalopathy (CTE). Understanding the pathophysiological mechanisms, epidemiology, and available diagnostic and therapeutic strategies is crucial for reducing risk and improving treatment outcomes of these injuries.
- Open Access
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67855
Diabetic Retinopathy: Pathogenesis, Clinical Features and the Role of Physical Activity in Prevention and Management
Background Diabetic retinopathy (DR) is a vision-threatening microvascular complication of diabetes mellitus that affects the retina and is classified into non-proliferative (NDPR) and proliferative (PDR) forms with diabetic macular edema (DME) representing an additional sight-threatening manifestation. Aim This study provides a comprehensive overview of diabetic retinopathy, integrating current knowledge of its pathogenesis, risk factors, clinical features, diagnostic methods, treatment options and potential impact of physical activity on disease prevention and progression. Material and methods This study was conducted as a review of the selected literature on diabetic retinopathy available in the PubMed database. Keywords included “Diabetic retinopathy”, “Nonproliferative diabetic retinopathy”, “Proliferative diabetic retinopathy”, “Glycemic control”, “ Physical activity”. Results Diabetic retinopathy can remain asymptomatic for long periods, making regular eye examinations essential for its early detection. Strict control of blood glucose and blood pressure helps prevent the onset and slow the progression of diabetic retinopathy with inflammation playing a central role in its pathogenesis. In addition, physical activity is associated with a reduced risk of DR with a particularly strong protective effect against vision-threatening diabetic retinopathy (VTDR). Current treatments include intravitreal corticosteroids, anti-VEGF agents, vitrectomy and laser photocoagulation. Early diagnosis combined with optimized management can significantly reduce the risk of permanent visual loss. Conclusion Diabetic retinopathy is a primary contributor to vision loss in working-age adults in developed countries. Growing insights into its pathogenesis and the discovery of new therapeutic targets offer promising opportunities for improved treatment.
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67855
Open AccessDiabetic Retinopathy: Pathogenesis, Clinical Features and the Role of Physical Activity in Prevention and Management
Background Diabetic retinopathy (DR) is a vision-threatening microvascular complication of diabetes mellitus that affects the retina and is classified into non-proliferative (NDPR) and proliferative (PDR) forms with diabetic macular edema (DME) representing an additional sight-threatening manifestation. Aim This study provides a comprehensive overview of diabetic retinopathy, integrating current knowledge of its pathogenesis, risk factors, clinical features, diagnostic methods, treatment options and potential impact of physical activity on disease prevention and progression. Material and methods This study was conducted as a review of the selected literature on diabetic retinopathy available in the PubMed database. Keywords included “Diabetic retinopathy”, “Nonproliferative diabetic retinopathy”, “Proliferative diabetic retinopathy”, “Glycemic control”, “ Physical activity”. Results Diabetic retinopathy can remain asymptomatic for long periods, making regular eye examinations essential for its early detection. Strict control of blood glucose and blood pressure helps prevent the onset and slow the progression of diabetic retinopathy with inflammation playing a central role in its pathogenesis. In addition, physical activity is associated with a reduced risk of DR with a particularly strong protective effect against vision-threatening diabetic retinopathy (VTDR). Current treatments include intravitreal corticosteroids, anti-VEGF agents, vitrectomy and laser photocoagulation. Early diagnosis combined with optimized management can significantly reduce the risk of permanent visual loss. Conclusion Diabetic retinopathy is a primary contributor to vision loss in working-age adults in developed countries. Growing insights into its pathogenesis and the discovery of new therapeutic targets offer promising opportunities for improved treatment.
- Open Access
- 17 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67655
The use of ambroxol in various fields of medicine outside medical indications - A Review of the Current Literature
Introduction: Ambroxol is a drug that has a multifaceted application in medicine. Its main effects are mucolytic, mucokinetic, anti-inflammatory, antioxidant and local anesthetic. Ambroxol is used in various fields of medicine, including in the treatment of respiratory diseases, supporting the production of surfactant, treating sore throat and neuropathic pain. Ambroxol has been identified as a component that enhances the enzymatic activity of mutated glucocerebrosidase resulting from various mutations resulting from misfolding mutations in the GBA gene [1]. Experimental studies are also underway on the treatment of neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis as well as in the treatment of stroke and inhibition of Clostridioides difficile toxins TcdA and TcdB. This article highlights the variety of applications of ambroxol, which was initially used only in respiratory diseases. Study Objective: The aim of this article is to comprehensively review the literature on the use of ambroxol in various fields of medicine in order to expand the research and use of ambroxol in diseases beyond its registered indications. Materials and Methods: Electronic database including PubMed, science networks, Google Scholar, to identify studies and literature reviews on the use of ambroxol in various fields of medicine. State of the Art: This review examines the use of ambroxol beyond its medical indications, mainly emphasizing its use in neuropathic pain, Parkinson's disease, amyotrophic lateral sclerosis, Gaucher's disease. Attention is also paid to its use in stroke patients and in the inhibition of Clostridioides difficile toxins TcdA and TcdB. Conclusion: Ambroxol is an antitussive drug that has been used for years. More and more studies are available on the use of ambroxol beyond its medical indications, which show the validity of the concept of its use in other fields of medicine than respiratory diseases.
- 17 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67655
Open AccessThe use of ambroxol in various fields of medicine outside medical indications - A Review of the Current Literature
Introduction: Ambroxol is a drug that has a multifaceted application in medicine. Its main effects are mucolytic, mucokinetic, anti-inflammatory, antioxidant and local anesthetic. Ambroxol is used in various fields of medicine, including in the treatment of respiratory diseases, supporting the production of surfactant, treating sore throat and neuropathic pain. Ambroxol has been identified as a component that enhances the enzymatic activity of mutated glucocerebrosidase resulting from various mutations resulting from misfolding mutations in the GBA gene [1]. Experimental studies are also underway on the treatment of neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis as well as in the treatment of stroke and inhibition of Clostridioides difficile toxins TcdA and TcdB. This article highlights the variety of applications of ambroxol, which was initially used only in respiratory diseases. Study Objective: The aim of this article is to comprehensively review the literature on the use of ambroxol in various fields of medicine in order to expand the research and use of ambroxol in diseases beyond its registered indications. Materials and Methods: Electronic database including PubMed, science networks, Google Scholar, to identify studies and literature reviews on the use of ambroxol in various fields of medicine. State of the Art: This review examines the use of ambroxol beyond its medical indications, mainly emphasizing its use in neuropathic pain, Parkinson's disease, amyotrophic lateral sclerosis, Gaucher's disease. Attention is also paid to its use in stroke patients and in the inhibition of Clostridioides difficile toxins TcdA and TcdB. Conclusion: Ambroxol is an antitussive drug that has been used for years. More and more studies are available on the use of ambroxol beyond its medical indications, which show the validity of the concept of its use in other fields of medicine than respiratory diseases.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
SPORT-RELATED DYSTONIA – CURRENT STATE OF KNOWLEDGE IN DIAGNOSIS AND TREATMENT
Sports-related dystonia (SRD) is believed to arise as a consequence of repetitive motor activity, often involving tens of thousands of movement repetitions performed during high-level athletic training. Professional sports practice is characterized by prolonged physical exertion and the frequent execution of specific motor tasks, repeated hundreds or even thousands of times in pursuit of technical perfection. This intensive regimen may lead to both physical and mental fatigue, potentially resulting in overuse injuries. SRD has been most frequently described in golfers, runners, cricketers, basketball players, and gymnasts. Despite growing awareness of its clinical presentation, SRD remains a diagnostic and therapeutic challenge.The aim of this study is to provide a comprehensive review of the current state of knowledge regarding SRD, based on publications available in the PubMed database.A literature search was conducted using relevant keywords to identify scientific publications not older than five years, retrieved from academic databases. SRD represents a complex clinical syndrome that requires a multidisciplinary and individualized approach. The absence of specific diagnostic tests, combined with the variability and subtlety of symptoms, often results in significant diagnostic challenges. Effective treatment must be tailored to the specific symptom profile presented by each athlete, taking into account both motor and non-motor aspects of the condition. Currently, further research is needed to improve both the diagnostic criteria and therapeutic strategies for managing SRD. Early identification and preventive strategies—particularly in young athletes—should be emphasized. Educational efforts aimed at raising awareness of the potential career-threatening nature of SRD may facilitate earlier recognition of symptoms and help prevent premature discontinuation of athletic careers.Treatment of this disorder must be individualized and focused on the specific range of symptoms present in each athlete. Currently, further research on the diagnosis and therapeutic options for patients affected by this condition is necessary.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessSPORT-RELATED DYSTONIA – CURRENT STATE OF KNOWLEDGE IN DIAGNOSIS AND TREATMENT
Sports-related dystonia (SRD) is believed to arise as a consequence of repetitive motor activity, often involving tens of thousands of movement repetitions performed during high-level athletic training. Professional sports practice is characterized by prolonged physical exertion and the frequent execution of specific motor tasks, repeated hundreds or even thousands of times in pursuit of technical perfection. This intensive regimen may lead to both physical and mental fatigue, potentially resulting in overuse injuries. SRD has been most frequently described in golfers, runners, cricketers, basketball players, and gymnasts. Despite growing awareness of its clinical presentation, SRD remains a diagnostic and therapeutic challenge.The aim of this study is to provide a comprehensive review of the current state of knowledge regarding SRD, based on publications available in the PubMed database.A literature search was conducted using relevant keywords to identify scientific publications not older than five years, retrieved from academic databases. SRD represents a complex clinical syndrome that requires a multidisciplinary and individualized approach. The absence of specific diagnostic tests, combined with the variability and subtlety of symptoms, often results in significant diagnostic challenges. Effective treatment must be tailored to the specific symptom profile presented by each athlete, taking into account both motor and non-motor aspects of the condition. Currently, further research is needed to improve both the diagnostic criteria and therapeutic strategies for managing SRD. Early identification and preventive strategies—particularly in young athletes—should be emphasized. Educational efforts aimed at raising awareness of the potential career-threatening nature of SRD may facilitate earlier recognition of symptoms and help prevent premature discontinuation of athletic careers.Treatment of this disorder must be individualized and focused on the specific range of symptoms present in each athlete. Currently, further research on the diagnosis and therapeutic options for patients affected by this condition is necessary.
- Open Access
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
ADRENAL GLANDS FUNCTION AND ORTHOSTATIC INTOLERANCE IN ATHLETES: IMPLICATIONS FOR SPORTS PERFORMANCE AND TRAINING MANAGEMENT
Orthostatic intolerance (OI) encompasses a spectrum of conditions characterized by impaired cardiovascular regulation upon standing, leading to symptoms such as dizziness, fatigue, lightheadedness, syncope, and reduced exercise tolerance. While frequently studied in clinical settings, OI remains underrecognized in athletes, where its impact on performance, recovery, and well-being may be substantial. This narrative review examines the physiological basis of OI with a particular focus on adrenal gland function—namely the secretion of cortisol, aldosterone, and catecholamines—and their role in maintaining orthostatic stability. It explores how factors specific to athletic populations, such as intense training intensity, dehydration, and relative energy deficiency (RED-S), can impair autonomic and adrenal responses. Diagnostic strategies including orthostatic testing and hormonal profiling are discussed, along with the need for dynamic assessments that reflect functional hormone reserve. Management options range from non-pharmacologic interventions like fluid and salt optimization to pharmacological support in severe cases. The article also highlights the importance of athlete education, training periodization, and coach involvement. Finally, future research priorities are outlined, including sex-specific hormonal dynamics, wearable monitoring, and early biomarkers of dysregulation. Increasing awareness of OI in athletic settings and its hormonal underpinnings can contribute to more effective detection, prevention, and treatment strategies—ultimately improving health outcomes and sustaining high performance.
- 18 December 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (4(48))
Open AccessADRENAL GLANDS FUNCTION AND ORTHOSTATIC INTOLERANCE IN ATHLETES: IMPLICATIONS FOR SPORTS PERFORMANCE AND TRAINING MANAGEMENT
Orthostatic intolerance (OI) encompasses a spectrum of conditions characterized by impaired cardiovascular regulation upon standing, leading to symptoms such as dizziness, fatigue, lightheadedness, syncope, and reduced exercise tolerance. While frequently studied in clinical settings, OI remains underrecognized in athletes, where its impact on performance, recovery, and well-being may be substantial. This narrative review examines the physiological basis of OI with a particular focus on adrenal gland function—namely the secretion of cortisol, aldosterone, and catecholamines—and their role in maintaining orthostatic stability. It explores how factors specific to athletic populations, such as intense training intensity, dehydration, and relative energy deficiency (RED-S), can impair autonomic and adrenal responses. Diagnostic strategies including orthostatic testing and hormonal profiling are discussed, along with the need for dynamic assessments that reflect functional hormone reserve. Management options range from non-pharmacologic interventions like fluid and salt optimization to pharmacological support in severe cases. The article also highlights the importance of athlete education, training periodization, and coach involvement. Finally, future research priorities are outlined, including sex-specific hormonal dynamics, wearable monitoring, and early biomarkers of dysregulation. Increasing awareness of OI in athletic settings and its hormonal underpinnings can contribute to more effective detection, prevention, and treatment strategies—ultimately improving health outcomes and sustaining high performance.
- Open Access
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Celiac Disease as an Underlying Cause of Multisystemic Symptoms: Consequences of Delayed Diagnosis - A Literature Review
Introduction and purpose Celiac disease (CD) is an autoimmune disorder that develops in genetically predisposed individuals in response to gluten intake. The overall prevalence of CD is approximately 0.75% in the general population, making it a condition frequently encountered in everyday clinical practice. CD impacts multiple organ systems. This paper describes its influence on, among others, the skin and mucous membranes, hematological parameters, bone health, reproductive function, and neuropsychiatric status. This review aims to summarize current evidence on the extraintestinal manifestations of this condition and highlight the importance of early recognition of these diverse symptoms. A brief description of the state of knowledge A comprehensive literature review was conducted using PubMed and MDPI databases. The analysis included original articles, reviews, and meta-analyses related to extraintestinal symptoms of CD, with emphasis on publications from the last ten years. The findings suggest that such symptoms are common and frequently non-specific, which frequently contributes to diagnostic delays. Many of them may occur before gastrointestinal symptoms or appear as isolated signs, leading to underdiagnosis and untreated disease. Summary Many extraintestinal symptoms of CD are still overlooked by clinicians. Improving healthcare professionals’ awareness of these symptoms may lead to earlier diagnosis and earlier initiation of a gluten-free diet. Timely treatment can help avoid long-term complications and significantly improve patients’ prognosis and quality of life.
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Open AccessCeliac Disease as an Underlying Cause of Multisystemic Symptoms: Consequences of Delayed Diagnosis - A Literature Review
Introduction and purpose Celiac disease (CD) is an autoimmune disorder that develops in genetically predisposed individuals in response to gluten intake. The overall prevalence of CD is approximately 0.75% in the general population, making it a condition frequently encountered in everyday clinical practice. CD impacts multiple organ systems. This paper describes its influence on, among others, the skin and mucous membranes, hematological parameters, bone health, reproductive function, and neuropsychiatric status. This review aims to summarize current evidence on the extraintestinal manifestations of this condition and highlight the importance of early recognition of these diverse symptoms. A brief description of the state of knowledge A comprehensive literature review was conducted using PubMed and MDPI databases. The analysis included original articles, reviews, and meta-analyses related to extraintestinal symptoms of CD, with emphasis on publications from the last ten years. The findings suggest that such symptoms are common and frequently non-specific, which frequently contributes to diagnostic delays. Many of them may occur before gastrointestinal symptoms or appear as isolated signs, leading to underdiagnosis and untreated disease. Summary Many extraintestinal symptoms of CD are still overlooked by clinicians. Improving healthcare professionals’ awareness of these symptoms may lead to earlier diagnosis and earlier initiation of a gluten-free diet. Timely treatment can help avoid long-term complications and significantly improve patients’ prognosis and quality of life.
- Open Access
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
The Bidirectional Relationship Between Obstructive Sleep Apnea and Obesity – A Literature Review
Introduction and purpose Obstructive sleep apnea (OSA) is recognized as one of the most prevalent sleep-related breathing disorders worldwide, affecting up to one billion adults aged 30 to 69 years. This disorder is characterized by recurrent episodes of upper airway collapse during sleep, leading to partial (hypopnea) or complete (apnea) cessation of airflow despite ongoing respiratory effort. These events cause intermittent oxygen desaturation and fragmented sleep architecture, resulting in significant daytime symptoms and adverse health outcomes. The current review aims to elucidate the complex bidirectional relationship between obstructive sleep apnea and obesity, emphasizing the necessity of a comprehensive and integrated clinical approach for the diagnosis, treatment, and management of these intertwined conditions. A brief description of the state of knowledge A systematic literature review was performed using PubMed and MDPI databases, encompassing original research articles, systematic reviews, and meta-analyses focusing on obstructive sleep apnea, with particular attention to publications from the last twenty years. The evidence consistently supports a reciprocal association between obesity and obstructive sleep apnea. Additionally, the effect of continuous positive airway pressure (CPAP) therapy on body weight is unclear, with weight gain primarily reported in patients who have poor adherence to the treatment. Summary Due to the lack of conclusive data, future investigations should focus on delineating the hormonal and physiological mechanisms that underpin OSA–obesity interaction, optimizing CPAP treatment protocols, and developing targeted weight management strategies tailored for this high-risk patient population. Moreover, clinicians should strongly advocate for the implementation of concurrent behavioral interventions alongside CPAP therapy to mitigate the risk of therapy-associated weight gain and improve overall patient outcomes.
- 25 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81
Open AccessThe Bidirectional Relationship Between Obstructive Sleep Apnea and Obesity – A Literature Review
Introduction and purpose Obstructive sleep apnea (OSA) is recognized as one of the most prevalent sleep-related breathing disorders worldwide, affecting up to one billion adults aged 30 to 69 years. This disorder is characterized by recurrent episodes of upper airway collapse during sleep, leading to partial (hypopnea) or complete (apnea) cessation of airflow despite ongoing respiratory effort. These events cause intermittent oxygen desaturation and fragmented sleep architecture, resulting in significant daytime symptoms and adverse health outcomes. The current review aims to elucidate the complex bidirectional relationship between obstructive sleep apnea and obesity, emphasizing the necessity of a comprehensive and integrated clinical approach for the diagnosis, treatment, and management of these intertwined conditions. A brief description of the state of knowledge A systematic literature review was performed using PubMed and MDPI databases, encompassing original research articles, systematic reviews, and meta-analyses focusing on obstructive sleep apnea, with particular attention to publications from the last twenty years. The evidence consistently supports a reciprocal association between obesity and obstructive sleep apnea. Additionally, the effect of continuous positive airway pressure (CPAP) therapy on body weight is unclear, with weight gain primarily reported in patients who have poor adherence to the treatment. Summary Due to the lack of conclusive data, future investigations should focus on delineating the hormonal and physiological mechanisms that underpin OSA–obesity interaction, optimizing CPAP treatment protocols, and developing targeted weight management strategies tailored for this high-risk patient population. Moreover, clinicians should strongly advocate for the implementation of concurrent behavioral interventions alongside CPAP therapy to mitigate the risk of therapy-associated weight gain and improve overall patient outcomes.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
MULTIPLE APPLICATIONS OF COLD ATMOSPHERIC PLASMA IN MEDICINE
Background: Cold atmospheric plasma (CAP) is a partially ionized gas produced at near-room temperature and atmospheric pressure. It has gained significant interest in recent years due to its diverse biomedical applications, especially in oncology, dermatology, and wound healing. The therapeutic potential of CAP is primarily based on the generation of reactive oxygen and nitrogen species (RONS), as well as minor ultraviolet radiation. Aim: The aim of this review is to summarize current knowledge from 2020 to 2025 regarding the biological effects and clinical applications of CAP, with particular emphasis on its role in cancer treatment, dermatological conditions, and wound management. Material and methods: A literature review was conducted using the PubMed database, focusing on articles published in English between 2016 and 2025 with a particular focus on recent evidence from 2021 to 2025 that address the medical use of CAP. Studies without full text, control groups, or of poor methodological quality were excluded. Results: In oncology, CAP demonstrates selective cytotoxic effects against tumor cells by disrupting cellular signaling, inducing oxidative stress, and modulating the tumor microenvironment. Studies report efficacy in cancers such as melanoma, breast cancer, and head and neck tumors. In dermatology, CAP exhibits antimicrobial activity, enhances skin barrier repair, modulates immune responses, and improves transdermal drug delivery. In wound care, CAP supports tissue regeneration by promoting cell proliferation, angiogenesis, and the breakdown of microbial biofilms. Conclusions: CAP is a promising tool in modern medicine with broad therapeutic potential. Despite encouraging results, further research is necessary to standardize treatment protocols, ensure long-term safety, and optimize plasma devices for clinical use.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessMULTIPLE APPLICATIONS OF COLD ATMOSPHERIC PLASMA IN MEDICINE
Background: Cold atmospheric plasma (CAP) is a partially ionized gas produced at near-room temperature and atmospheric pressure. It has gained significant interest in recent years due to its diverse biomedical applications, especially in oncology, dermatology, and wound healing. The therapeutic potential of CAP is primarily based on the generation of reactive oxygen and nitrogen species (RONS), as well as minor ultraviolet radiation. Aim: The aim of this review is to summarize current knowledge from 2020 to 2025 regarding the biological effects and clinical applications of CAP, with particular emphasis on its role in cancer treatment, dermatological conditions, and wound management. Material and methods: A literature review was conducted using the PubMed database, focusing on articles published in English between 2016 and 2025 with a particular focus on recent evidence from 2021 to 2025 that address the medical use of CAP. Studies without full text, control groups, or of poor methodological quality were excluded. Results: In oncology, CAP demonstrates selective cytotoxic effects against tumor cells by disrupting cellular signaling, inducing oxidative stress, and modulating the tumor microenvironment. Studies report efficacy in cancers such as melanoma, breast cancer, and head and neck tumors. In dermatology, CAP exhibits antimicrobial activity, enhances skin barrier repair, modulates immune responses, and improves transdermal drug delivery. In wound care, CAP supports tissue regeneration by promoting cell proliferation, angiogenesis, and the breakdown of microbial biofilms. Conclusions: CAP is a promising tool in modern medicine with broad therapeutic potential. Despite encouraging results, further research is necessary to standardize treatment protocols, ensure long-term safety, and optimize plasma devices for clinical use.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
BEYOND THE GUT: EXPLORING NEUROLOGICAL IMPLICATIONS OF CELIAC DISEASE
Introduction and purpose: The aim of this article is to provide a comprehensive review of the neurological manifestations associated with celiac disease (CD), a systemic autoimmune disorder triggered by gluten in genetically predisposed individuals. Although CD is traditionally associated with gastrointestinal symptoms, its neurological effects are increasingly recognized and require further analysis. Material and methods: This narrative review was conducted using literature sourced from scientific databases including PubMed, Scopus, Web of Science, and Google Scholar. State of knowledge: Neurological symptoms in CD, such as cerebellar ataxia, peripheral neuropathy, cognitive impairment, seizures, and”brain fog, ” may precede or occur without gastrointestinal symptoms. Diagnostic strategies include genetic and serological testing, neuroimaging, and neurological assessments. Although a gluten-free diet remains the cornerstone of therapy, additional treatments such as vitamin E supplementation and intravenous immunoglobulin have shown promise in specific cases. Results: Neurological symptoms affect a significant proportion of patients with celiac disease, and early diagnosis combined with strict adherence to a gluten-free diet improves treatment outcomes. Quality of life and mental well-being also improve, which is particularly noticeable in the first year of treatment. Celiac disease is characterized by a diverse spectrum of neurological symptoms that may remain undiagnosed without a multidisciplinary approach.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(47))
Open AccessBEYOND THE GUT: EXPLORING NEUROLOGICAL IMPLICATIONS OF CELIAC DISEASE
Introduction and purpose: The aim of this article is to provide a comprehensive review of the neurological manifestations associated with celiac disease (CD), a systemic autoimmune disorder triggered by gluten in genetically predisposed individuals. Although CD is traditionally associated with gastrointestinal symptoms, its neurological effects are increasingly recognized and require further analysis. Material and methods: This narrative review was conducted using literature sourced from scientific databases including PubMed, Scopus, Web of Science, and Google Scholar. State of knowledge: Neurological symptoms in CD, such as cerebellar ataxia, peripheral neuropathy, cognitive impairment, seizures, and”brain fog, ” may precede or occur without gastrointestinal symptoms. Diagnostic strategies include genetic and serological testing, neuroimaging, and neurological assessments. Although a gluten-free diet remains the cornerstone of therapy, additional treatments such as vitamin E supplementation and intravenous immunoglobulin have shown promise in specific cases. Results: Neurological symptoms affect a significant proportion of patients with celiac disease, and early diagnosis combined with strict adherence to a gluten-free diet improves treatment outcomes. Quality of life and mental well-being also improve, which is particularly noticeable in the first year of treatment. Celiac disease is characterized by a diverse spectrum of neurological symptoms that may remain undiagnosed without a multidisciplinary approach.
- Open Access
- 10 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 62423
Physical Activity in the Prevention and Management of Type 2 Diabetes Evidence-Based Approaches
Type 2 diabetes mellitus (T2DM) is a growing global health concern linked to sedentary lifestyles and obesity. Physical activity is a key factor in prevention and management, yet existing guidelines may not fully address the needs of physically active individuals. This narrative review synthesizes data from randomized controlled trials, systematic reviews, meta-analyses, and expert guidelines from the past 15 years. It focuses on the metabolic effects of exercise and practical recommendations tailored to various activity levels. Structured physical activity improves insulin sensitivity, lowers HbA1c, supports weight control, and reduces cardiovascular risk. Combined aerobic and resistance training yields the most consistent benefits. In active individuals, monitoring glucose levels, preventing hypoglycemia, and adjusting training volume are essential. Digital tools and interdisciplinary care can enhance adherence and safety. Physical activity is a cornerstone of T2DM care. Individualized exercise strategies aligned with fitness level and treatment needs can optimize outcomes. Future studies should focus on highly active populations and technology-based interventions to support personalized, sustainable exercise programs.
- 10 July 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 43, 62423
Open AccessPhysical Activity in the Prevention and Management of Type 2 Diabetes Evidence-Based Approaches
Type 2 diabetes mellitus (T2DM) is a growing global health concern linked to sedentary lifestyles and obesity. Physical activity is a key factor in prevention and management, yet existing guidelines may not fully address the needs of physically active individuals. This narrative review synthesizes data from randomized controlled trials, systematic reviews, meta-analyses, and expert guidelines from the past 15 years. It focuses on the metabolic effects of exercise and practical recommendations tailored to various activity levels. Structured physical activity improves insulin sensitivity, lowers HbA1c, supports weight control, and reduces cardiovascular risk. Combined aerobic and resistance training yields the most consistent benefits. In active individuals, monitoring glucose levels, preventing hypoglycemia, and adjusting training volume are essential. Digital tools and interdisciplinary care can enhance adherence and safety. Physical activity is a cornerstone of T2DM care. Individualized exercise strategies aligned with fitness level and treatment needs can optimize outcomes. Future studies should focus on highly active populations and technology-based interventions to support personalized, sustainable exercise programs.